These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9415125)

  • 1. An Alzheimer's mouse at last?
    Altman J
    Mol Med Today; 1995 Apr; 1(1):1. PubMed ID: 9415125
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological transgenic mouse models of Alzheimer's disease.
    Crews L; Rockenstein E; Masliah E
    Handb Clin Neurol; 2008; 89():291-301. PubMed ID: 18631753
    [No Abstract]   [Full Text] [Related]  

  • 3. Transgenic mouse models of Alzheimer's disease.
    Hock BJ; Lamb BT
    Trends Genet; 2001 Oct; 17(10):S7-12. PubMed ID: 11585670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations at codon 717 of the beta-amyloid precursor protein gene are a cause of Alzheimer's disease.
    Kumar S
    Indian J Exp Biol; 1992 Feb; 30(2):156. PubMed ID: 1521868
    [No Abstract]   [Full Text] [Related]  

  • 5. Transgenic models for Alzheimer's disease.
    Duff K
    Neuropathol Appl Neurobiol; 1998 Apr; 24(2):101-3. PubMed ID: 9634205
    [No Abstract]   [Full Text] [Related]  

  • 6. New hopes arise with the transgenic model for Alzheimer's disease.
    Kotula L; Wisniewski HM
    Neurobiol Aging; 1995; 16(4):701-3. PubMed ID: 8544922
    [No Abstract]   [Full Text] [Related]  

  • 7. Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.
    Hansen HH; Fabricius K; Barkholt P; Kongsbak-Wismann P; Schlumberger C; Jelsing J; Terwel D; Termont A; Pyke C; Knudsen LB; Vrang N
    PLoS One; 2016; 11(7):e0158205. PubMed ID: 27421117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal models of Alzheimer's disease.
    Higgins LS
    Mol Med Today; 1999 Jun; 5(6):274-6. PubMed ID: 10475711
    [No Abstract]   [Full Text] [Related]  

  • 9. Alzheimer's disease aetiology: amyloid and chromosome 14.
    Houlden H; Mullan M
    Br J Hosp Med; 1993 Apr 21-May 4; 49(8):535-6. PubMed ID: 8508237
    [No Abstract]   [Full Text] [Related]  

  • 10. A promising animal model of Alzheimer's disease.
    Tanzi RE
    N Engl J Med; 1995 Jun; 332(22):1512-3. PubMed ID: 7739692
    [No Abstract]   [Full Text] [Related]  

  • 11. A decade of modeling Alzheimer's disease in transgenic mice.
    McGowan E; Eriksen J; Hutton M
    Trends Genet; 2006 May; 22(5):281-9. PubMed ID: 16567017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models.
    Mi W; Pawlik M; Sastre M; Jung SS; Radvinsky DS; Klein AM; Sommer J; Schmidt SD; Nixon RA; Mathews PM; Levy E
    Nat Genet; 2007 Dec; 39(12):1440-2. PubMed ID: 18026100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development of transgenic animal models for Alzheimer's disease].
    Watanabe N; Tabira T
    No To Shinkei; 2001 Sep; 53(9):809-20. PubMed ID: 11596475
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanisms of memory loss in Abeta and tau mouse models.
    Ashe KH
    Biochem Soc Trans; 2005 Aug; 33(Pt 4):591-4. PubMed ID: 16042551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monogenetic determinants of Alzheimer's disease: APP mutations.
    Goate AM
    Cell Mol Life Sci; 1998 Sep; 54(9):897-901. PubMed ID: 9791531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted introduction of V642I mutation in amyloid precursor protein gene causes functional abnormality resembling early stage of Alzheimer's disease in aged mice.
    Kawasumi M; Chiba T; Yamada M; Miyamae-Kaneko M; Matsuoka M; Nakahara J; Tomita T; Iwatsubo T; Kato S; Aiso S; Nishimoto I; Kouyama K
    Eur J Neurosci; 2004 May; 19(10):2826-38. PubMed ID: 15147316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Creating the mouse that roared.
    Emerson D
    Minn Med; 2001 May; 84(5):6-9. PubMed ID: 11398634
    [No Abstract]   [Full Text] [Related]  

  • 18. Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease.
    Poduslo JF; Curran GL; Wengenack TM; Malester B; Duff K
    Neurobiol Dis; 2001 Aug; 8(4):555-67. PubMed ID: 11493021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inherited neurodegenerative diseases and transgenic models.
    Borchelt DR
    Lab Anim Sci; 1998 Dec; 48(6):604-10. PubMed ID: 10090084
    [No Abstract]   [Full Text] [Related]  

  • 20. Intraneuronal APP and extracellular Aβ independently cause dendritic spine pathology in transgenic mouse models of Alzheimer's disease.
    Zou C; Montagna E; Shi Y; Peters F; Blazquez-Llorca L; Shi S; Filser S; Dorostkar MM; Herms J
    Acta Neuropathol; 2015 Jun; 129(6):909-20. PubMed ID: 25862638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.